A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-520490-38-00

Acronym

NN7442-8454

Enrollment

Registered

2025-09-22

Start date

2025-10-13

Completion date

Unknown

Last updated

2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia A with or without inhibitors. Proposed indication under development: prevention of bleeding and long-term prophylaxis in patients with haemophilia A, irrespective of inhibitor status or severity.

Interventions

None listed

Eligibility

Sex/Gender

Male

Age

18 Years to 64 Years

Countries

Austria, Germany, Italy, Poland, Spain

Outcome results